Health In Tech earnings release, May 13, 2026

Health In Tech, Inc. (HIT) · Form 8-K, Item 2.02 · Filed · SEC filing

Health In Tech Reports First Quarter 2026 Financial

Results

Reiterates Guidance for 2026 Annual Revenue

Ranging between $45 Million and $50 Million

Stuart, FL., May 13, 2026 /PRNewswire/ — Health In Tech, Inc. (Nasdaq: HIT) (“Health In Tech” or “Company”), an AI-enabled InsurTech platform company, today announced its unaudited financial results for the three months ended March 31, 2026.

First Quarter 2026 Overview

As of March 31, 2026

2026 Full Year Revenue Guidance

Health In Tech today reiterated guidance for 2026 annual revenue ranging between $45 million and $50 million, representing year-over-year growth of approximately 35% to 50%. As of March 31, 2026, the Company’s contracted revenue for the remaining three quarters of 2026 totaled $22.9 million, which the Company believes provides useful visibility into 2026 full year revenue. Health In Tech’s revenue outlook is based on management’s current expectations and assumptions, including continued strong demand for the Company’s AI-enabled underwriting marketplace across the self-funded health insurance segment and successful deployment of new features. Actual results may differ materially due to risks and uncertainties described in Health In Tech’s filings with the SEC.

The Company expects continued growth driven by expanding engagement across its distribution network and the full deployment of new features launched in January 2026. Unlike the traditional insurance industry, where new product and service implementations typically require one to two years, Health In Tech’s AI-driven platform enables new capabilities to be developed and deployed within approximately one to two quarters. This accelerated development cycle provides a meaningful competitive advantage, allowing the Company to respond quickly to broker and client demand, continuously enhance its marketplace offerings, and scale its technology platform more efficiently than traditional market participants.

CEO Commentary

Tim Johnson, Chief Executive Officer of Health

In Tech, commented, “In the first quarter of 2026, we continued to execute on strategic priorities to scale our innovative AI-powered self-funded health insurance marketplace and drive revenue growth. In March, we successfully completed a private investment in public equity financing, which provided the Company with approximately $7 million in gross proceeds. We intend to allocate a portion of these proceeds to growth initiatives, including expanding our sales team, broadening our marketing activities, delivering new marketplace offerings, and enhancing the technology architecture and data analytics that underpin our disruptive platform. Through these measures we aim to increase the number of brokers, agencies, third party administrators, and carriers that utilize our efficient, cost-effective ecosystem.”

Mr. Johnson continued, “We intend for 2026 to be a year of investing for growth and launching new solutions to further penetrate the vast U.S. self-funded health insurance market.

Our recently rolled out suite of more than 100 pre-configured, customized stop-loss plans as well as our new three-year rate stabilization program are poised to deliver meaningful revenue beginning in the second half of the year. We also are developing a data-driven offering that integrates physiological and claims data to generate actionable insights. By layering in new capabilities such as these onto our platform, we better serve our ecosystem partners and business employer end-clients, while creating new revenue streams and operating leverage for Health In Tech.”

End Notes

Conference Call Details

Health In Tech will host a conference call to discuss the financial results for the first quarter of 2026 on May 13, 2026, at 5:00 p.m. (ET). To participate in our live conference call and webcast, please dial 1-888-346-8982 or 1-412-902-4272 (for international participants).²

A live audio webcast will be available via the

Investor Relations page of Health In Tech’s website at https://healthintech.com/.

A replay of the webcast will be available for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days.

Non-GAAP Financial Information

This release presents Adjusted EBITDA, a non-GAAP financial metric, which is provided as a complement to the results provided in accordance with accounting principles generally accepted in the United States of America (“GAAP”). Management uses Adjusted EBITDA to provide investors with additional insight into operational performance and to facilitate comparison with other companies in the industry. Adjusted EBITDA should not be considered an alternative to net income, operating income, or other GAAP measures. A reconciliation of historical non-GAAP financial information to the most directly comparable GAAP financial measure is provided in the accompanying tables found at the end of this release.

Financial statements

Income Statement

Three Months Ended March 31, — (Unaudited)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
RevenuesRevenues from underwriting modeling (ICE)1,468,8142,351,984
RevenuesRevenues from fees (SMR)7,302,8325,663,000
RevenuesTotal revenues8,771,6468,014,984
RevenuesCost of revenues4,262,2472,659,585
RevenuesGross profit4,509,3995,355,399
Operating expensesSales and marketing expenses2,291,6011,090,255
Operating expensesGeneral and administrative expenses3,455,5583,246,765
Operating expensesResearch and development expenses920,395537,721
Operating expensesTotal operating expenses6,667,5544,874,741
Other income:Interest income67,47185,366
Other income:Other income22,334118,399
Other income:Total other income, net89,805203,765
Other income:Income (loss) before income taxes-2,068,350684,423
Other income:Income tax benefit (expense)480,069-185,831
Other income:Net income (loss)-1,588,281498,592
Net income (loss) per shareBasic-0.030.01
Net income (loss) per shareDiluted-0.030.01
Weighted average common stocks outstandingBasic57,353,02154,619,858
Weighted average common stocks outstandingDiluted57,353,02156,996,936

Income Statement

Three Months Ended March 31, — Reconciliation of GAAP Net Income (Loss) to Non-GAAP Financial Measure Adjusted EBITDA

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
Net income (loss)-1,588,281498,592
Interest income-67,471-85,366
Amortization expense403,467135,983
Income tax expense (benefit)-480,069185,831
Stock-based compensation expense, including employer payroll taxes related to stock-based awards443,839493,171
Total net adjustments299,766729,619
Adjusted EBITDA-1,288,5151,228,211

Balance Sheet

March 31, 2026 — (Unaudited)

March 31, 2026December 31, 2025
Current assetsCash and cash equivalents10,325,2087,669,754
Current assetsAccounts receivable, net3,737,647756,288
Current assetsLoans receivable, net831,994815,995
Current assetsOther receivables, net4,328,4483,467,814
Current assetsDeferred offering costs170,977
Current assetsPrepaid expenses and other current assets2,864,5573,280,148
Current assetsTotal current assets22,087,85416,160,976
Non-current assetsSoftware6,708,5616,530,894
Non-current assetsOperating lease - right of use assets122,328139,940
Non-current assetsLong-term prepaid expenses47,464258,151
Non-current assetsTotal non-current assets6,878,3536,928,985
Non-current assetsTotal assets28,966,20723,089,961
Current liabilitiesAccounts payable and accrued expenses6,968,2614,188,811
Current liabilitiesOperating lease liabilities - current78,68076,195
Current liabilitiesOther current liabilities891,598
Current liabilitiesTotal current liabilities7,046,9415,156,604
Non-current liabilitiesDeferred tax liabilities273,203757,675
Non-current liabilitiesOperating lease liabilities - non-current42,91563,617
Non-current liabilitiesTotal non-current liabilities316,118821,292
Non-current liabilitiesTotal liabilities7,363,0595,977,896
Stockholders’ equityCommon stock, $0.001 par value; Class A Common stock 150,000,000 shares authorized 53,858,276 and 46,006,000 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively53,85846,006
Stockholders’ equityCommon stock, $0.001 par value; Class B Common stock 50,000,000 shares authorized, 11,700,000 shares issued and outstanding as of both March 31, 2026 and December 31, 202511,70011,700
Stockholders’ equityAdditional paid-in capital17,905,63311,834,121
Stockholders’ equityRetained earnings3,631,9575,220,238
Stockholders’ equityTotal stockholders’ equity21,603,14817,112,065
Stockholders’ equityTotal liabilities and stockholders’ equity28,966,20723,089,961

Cash Flow

Three Months Ended March 31, — (Unaudited)

Three Months Ended March 31, – 2026Three Months Ended March 31, – 2025
CASH FLOWS FROM OPERATING ACTIVITIES:Net income (loss)-1,588,281498,592
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:Amortization expense403,467135,983
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:Provision for refund liability108,402780,045
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:Deferred tax benefit-484,472-34,473
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:Interest income-15,999-15,999
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:Stock-based compensation expense366,562493,171
Changes in operating assets and liabilities:Accounts receivable-2,981,360-463,498
Changes in operating assets and liabilities:Other receivables-11,740-3,489,536
Changes in operating assets and liabilities:Prepaid expenses and other assets447,597-1,017,751
Changes in operating assets and liabilities:Operating lease right of use assets and liabilities, net-60519
Changes in operating assets and liabilities:Accounts payable and accrued expenses1,437,1823,420,497
Changes in operating assets and liabilities:Income taxes payable220,303
Changes in operating assets and liabilities:Other current liabilities-1,000,000
Changes in operating assets and liabilities:Net cash provided by (used in) operating activities-3,319,247527,353
Full release

Use of Forward-Looking Statements

Certain statements in this press release are forward-looking statements for purposes of the safe harbor provisions under the U.S. Private Securities Litigation Reform Act of 1995. Forward-looking statements may include estimates or expectations about Health In Tech’s possible or assumed operational results, financial condition, business strategies and plans, market opportunities, competitive position, industry environment, and potential growth opportunities. In some cases, forward-looking statements can be identified by terms such as “may,” “will,” “should,”

“design,” “target,” “aim,” “hope,” “expect,” “could,” “intend,”

“plan,” “anticipate,” “estimate,” “believe,” “continue,” “predict,”

“project,” “potential,” “goal,” or other words that convey the uncertainty of future events or outcomes.... (truncated)nancial performance, and involve known and unknown risks, uncertainties and other factors that may cause Health In Tech’s actual results, levels of activity, performance, or achievements to be different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. You should not place undue reliance on forward-looking statements because they involve known and unknown risks, uncertainties and other factors which are, in some cases, beyond Health In Tech’s control and which could, and likely will, affect actual results, levels of activity, performance or achievements. Any forward-looking statement reflects Health In Tech’s current views with respect to future events and is subject to these and other risks, uncertainties and assumptions relating to Health In Tech’s operations, results of operations, growth strategy and liquidity.

About Health In Tech

Health In Tech, Inc. (Nasdaq: “HIT”) is an AI-enabled InsurTech platform company, which offers a marketplace that improves processes in the health insurance industry through vertical integration, process simplification, and automation. By removing friction and complexities, we streamline the underwriting, sales and service process for insurance companies, licensed brokers, Managing General Underwriter (“MGUs”) and third-party administrators

(“TPAs”). Health In Tech’s platform serves as a marketplace for brokers, TPAs, MGUs and carriers to access self-funded health insurance for employers, providing functions including customized self-funded health plans, bindable stop-loss quotes, AI-enabled underwriting, claims administration and reporting integration.³

Health In Tech, Inc.

Consolidated Statements of Operations

(Unaudited)⁴

Health In Tech, Inc.

Consolidated Balance Sheets

(Unaudited)⁵

Health In Tech, Inc.

Consolidated Statements of Cash Flows

(Unaudited)⁶

Health In Tech, Inc.

Reconciliation of GAAP Net Income (Loss) to

Non-GAAP Financial Measure Adjusted EBITDA

Investor Contact:

Health In Tech Investor Relations ir@healthintech.com

The Equity Group

Kalle Ahl, CFA

T: (303) 953-9878 kahl@theequitygroup.com

Devin Sullivan, Managing Director dsullivan@theequitygroup.com⁷

From SEC EDGAR. Analysis by Pear Digitals from the filing alone. Not investment advice. · Health In Tech earnings · Latest earnings · Markdown

Screener

Plans

Premium and Pro coming soon.

Log in

New here?

Join the waitlist

Pear FMV opens to everyone soon. We'll email you when it does.